The best trial plans are based on a comprehensive and realistic understanding of the critical path and minimize the number of activities that must be on it – especially during study start up. Any delays in submissions or site initiations cause recruitment to fall behind schedule and can potentially delay the overall trial.

When it comes to the development and implementation of electronic Clinical Outcome Assessments (eCOAs), drug developers are too often surprised by the number of complex steps and individual service areas that must be in sync for an eCOA solution to be delivered on time.

In this whitepaper we describe what is involved in adopting an eCOA solution and share a recommended approach to planning and implementing eCOA that will eliminate surprises and mitigate the risks of delaying the study start up.